
NASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$154.68
−US$1.3475 · -0.86%
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
一般交易時段
US$154.68
−US$1.3475 · -0.86%
盤中時間採用ET。市場資料可能有所延遲。
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
日內區間
目前US$154.68
52週區間
目前US$154.68
盤中時間採用ET。市場資料可能有所延遲。
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
日內區間
目前US$154.68
52週區間
目前US$154.68
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 22.3億 USD | 23.82億 USD | 22.59億 USD | 22.8億 USD | 13.16億 USD |
| 銷貨成本 | 14.1億 USD | 15.57億 USD | 15.19億 USD | 15.82億 USD | 8.25億 USD |
| 毛利 | 8.2億 USD | 8.25億 USD | 7.4億 USD | 6.98億 USD | 4.91億 USD |
| 研究與開發 | 8749.5萬 USD | 8861.5萬 USD | 8534.4萬 USD | 9298.4萬 USD | 4749.8萬 USD |
| 銷售、一般及管理費用 | 6.25億 USD | 6.39億 USD | 6.07億 USD | 6.08億 USD | 3.03億 USD |
| 營業費用 | 7.13億 USD | 7.82億 USD | 7.17億 USD | 7.41億 USD | 3.68億 USD |
| 利息收入 | 1030.7萬 USD | 1078.8萬 USD | 750.8萬 USD | 443萬 USD | 284萬 USD |
| 利息支出 | 1.05億 USD | 1.07億 USD | 1.03億 USD | 7080.5萬 USD | 85.8萬 USD |
| 折舊和攤銷 | 2.01億 USD | 2.2億 USD | 2.29億 USD | 2.35億 USD | 8969.8萬 USD |
| 營業利益 | 1.07億 USD | 4296.4萬 USD | 2282.5萬 USD | −4289.8萬 USD | 1.23億 USD |
| 淨利 | 73.2萬 USD | −1.18億 USD | −2965.5萬 USD | −7428.6萬 USD | 1.03億 USD |
公司資料更新於 2026年10月8日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$186.4
上漲空間 20.50%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2002年3月18日 | 3:2 | — | — |
股票分割 | 1993年4月1日 | 3:2 | — | — |
已生效 2002年3月18日
3:2
已生效 1993年4月1日
3:2
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR2.33億0.23%1042.94億 USD0.06%US$136.65-0.31%
Vanguard Morningstar Total Stock Market ETFVTI1.37億0.01%2.3兆 USD0.03%US$380.2-0.22%
iShares Russell 2000 ETFIWM1.01億0.13%785.63億 USD0.19%US$276.14-0.56%
Vanguard Morningstar Small-Cap ETFVB9951.7萬0.05%1853億 USD0.03%US$286.31-0.24%
Vanguard Morningstar Small-Cap Value ETFVBR6316.36萬0.09%682億 USD0.05%US$232.22+0.02%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV5560.92萬0.21%266.88億 USD0.33%US$37.88+0.22%
Vanguard Extended Market ETFVXF5024.94萬0.05%954億 USD0.05%US$232.58-0.39%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM3679.09萬0.23%160.11億 USD0.03%US$53.1286-0.28%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。